Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the pharmacokinetics of the combination dapivirine and
maraviroc vaginal ring and determine whether it is safe when used continuously for 28 days by
healthy women in the United States.